These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 15801958)

  • 1. Risks factors for highly unstable response to oral anticoagulation: a case-control study.
    Palareti G; Legnani C; Guazzaloca G; Lelia V; Cosmi B; Lunghi B; Marchetti G; Poli D; Pengo V;
    Br J Haematol; 2005 Apr; 129(1):72-8. PubMed ID: 15801958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of patient capability to self-adjust oral anticoagulant dose: a multicenter study on home use of portable prothrombin time monitor (COAGUCHECK).
    Cosmi B; Palareti G; Carpanedo M; Pengo V; Biasiolo A; Rampazzo P; Morstabilini G; Testa S
    Haematologica; 2000 Aug; 85(8):826-31. PubMed ID: 10942929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acenocoumarol stabilization is delayed in CYP2C93 carriers.
    Schalekamp T; van Geest-Daalderop JH; de Vries-Goldschmeding H; Conemans J; Bernsen Mj Mj; de Boer A
    Clin Pharmacol Ther; 2004 May; 75(5):394-402. PubMed ID: 15116052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cytochrome P450 2C9 polymorphisms on phenprocoumon anticoagulation status.
    Schalekamp T; Oosterhof M; van Meegen E; van Der Meer FJ; Conemans J; Hermans M; Meijerman I; de Boer A
    Clin Pharmacol Ther; 2004 Nov; 76(5):409-17. PubMed ID: 15536456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance of cytochrome P450 2C9 genotype for the bleeding complications in patients treated with acenocoumarol].
    Márk L; Márki-Zay J; Fodor L; Kondacs A; Paragh G; Katona A
    Orv Hetil; 2005 Apr; 146(16):739-43. PubMed ID: 15889670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of patient adherence on anticoagulation control with warfarin: results from the International Normalized Ratio Adherence and Genetics (IN-RANGE) Study.
    Kimmel SE; Chen Z; Price M; Parker CS; Metlay JP; Christie JD; Brensinger CM; Newcomb CW; Samaha FF; Gross R
    Arch Intern Med; 2007 Feb; 167(3):229-35. PubMed ID: 17296877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study on the quality of oral anticoagulant therapy (warfarin versus acenocoumarol).
    Pattacini C; Manotti C; Pini M; Quintavalla R; Dettori AG
    Thromb Haemost; 1994 Feb; 71(2):188-91. PubMed ID: 8191397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Warfarin in the treatment of antiphospholipid syndrome].
    Reshetniak TM; Kondrat'eva LV; Patrusheva NL; Patrushev LI
    Ter Arkh; 2007; 79(5):47-54. PubMed ID: 17672075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allelic variants of cytochrome P450 2C9 modify the interaction between nonsteroidal anti-inflammatory drugs and coumarin anticoagulants.
    Visser LE; van Schaik RH; van Vliet M; Trienekens PH; De Smet PA; Vulto AG; Hofman A; van Duijn CM; Stricker BH
    Clin Pharmacol Ther; 2005 Jun; 77(6):479-85. PubMed ID: 15961979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytochrome P450 2C9 polymorphism and acenocoumarol therapy.
    Mark L; Marki-Zay J; Fodor L; Hajdara I; Paragh G; Katona A
    Kardiol Pol; 2006 Apr; 64(4):397-402; discussion 403-4. PubMed ID: 16699986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Knowledge of patients undergoing long-term acenocumarol treatment about the safety of anticoagulant therapy].
    Sawicka-Powierza J; Ołtarzewska AM; Chlabicz S
    Pol Merkur Lekarski; 2007 Jan; 22(127):36-40. PubMed ID: 17477088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poor anticoagulation quality in the first 3 months after unprovoked venous thromboembolism is a risk factor for long-term recurrence.
    Palareti G; Legnani C; Cosmi B; Guazzaloca G; Cini M; Mattarozzi S
    J Thromb Haemost; 2005 May; 3(5):955-61. PubMed ID: 15869591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomised control trial of patient self-management of oral anticoagulation compared with patient self-testing.
    Gardiner C; Williams K; Longair I; Mackie IJ; Machin SJ; Cohen H
    Br J Haematol; 2006 Mar; 132(5):598-603. PubMed ID: 16445833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-management of oral anticoagulation in the elderly: rationale, design, baselines and oral anticoagulation control after one year of follow-up. A randomized controlled trial.
    Siebenhofer A; Rakovac I; Kleespies C; Piso B; Didjurgeit U
    Thromb Haemost; 2007 Mar; 97(3):408-16. PubMed ID: 17334508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life.
    Gadisseur AP; Kaptein AA; Breukink-Engbers WG; van der Meer FJ; Rosendaal FR
    J Thromb Haemost; 2004 Apr; 2(4):584-91. PubMed ID: 15102012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CYP2C9 genotype-guided warfarin prescribing enhances the efficacy and safety of anticoagulation: a prospective randomized controlled study.
    Caraco Y; Blotnick S; Muszkat M
    Clin Pharmacol Ther; 2008 Mar; 83(3):460-70. PubMed ID: 17851566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of mental ability in elderly anticoagulated patients: its reduction is associated with a less satisfactory quality of treatment.
    Palareti G; Poggi M; Guazzaloca G; Savino A; Coccheri S
    Blood Coagul Fibrinolysis; 1997 Oct; 8(7):411-7. PubMed ID: 9391722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subtherapeutic oral anticoagulant therapy: frequency and risk factors.
    Rombouts EK; Rosendaal FR; van der Meer FJ
    Thromb Haemost; 2009 Mar; 101(3):552-6. PubMed ID: 19277419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary interactions and INR variability: retrospective evaluation of patients couples on oral anticoagulant therapy.
    Sottilotta G; Romeo E; Consonni D; Siboni S; Latella C; Oriana V; Trapani Lombardo V
    Minerva Med; 2011 Aug; 102(4):271-5. PubMed ID: 21959701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study.
    Clark NP; Witt DM; Delate T; Trapp M; Garcia D; Ageno W; Hylek EM; Crowther MA;
    Pharmacotherapy; 2008 Aug; 28(8):960-7. PubMed ID: 18657012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.